TWD 74.2
(-3.39%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 399.14 Million TWD | 54.11% |
2022 | 267.08 Million TWD | -5.17% |
2021 | 281.65 Million TWD | -18.34% |
2020 | 344.91 Million TWD | 34.9% |
2019 | 255.67 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 123.77 Million TWD | 59.17% |
2024 Q1 | 76.18 Million TWD | -38.25% |
2023 Q1 | 86.3 Million TWD | 10.62% |
2023 FY | 411.59 Million TWD | 54.11% |
2023 Q4 | 123.38 Million TWD | 0.37% |
2023 Q3 | 122.92 Million TWD | 55.62% |
2023 Q2 | 78.98 Million TWD | -8.47% |
2022 FY | 267.08 Million TWD | -5.17% |
2022 Q4 | 78.01 Million TWD | 0.0% |
2021 FY | 281.65 Million TWD | -18.34% |
2020 FY | 344.91 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | -153.066% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -200.596% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | -19.701% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 79.12% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 73.383% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 81.411% |
Center Laboratories, Inc. | 697.35 Million TWD | 42.763% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | -49.341% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 14.833% |
InnoPharmax Inc. | 82.29 Million TWD | -385.016% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -63.162% |
Excelsior Biopharma Inc. | 388.05 Million TWD | -2.858% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 30.612% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 64.412% |
UniPharma Co., Ltd. | 78.32 Million TWD | -409.632% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -0.558% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -376.624% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | -163.47% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -67323.818% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -311.57% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | -18.699% |